Kidron Miriam 4

What Happened
Miriam Kidron, Chief Scientific Officer and a director of Oramed Pharmaceuticals (ORMP), reported a charitable gift of 86,166 ORMP shares on January 14, 2026. The Form 4 shows the shares were donated (transaction code G) and reports a price of $0.00 because no cash was received; no dollar value was provided for the donated shares.

Key Details

• Transaction date: 2026-01-14 (reported on Form 4 filed 2026-01-21).
• Transaction type/code: Gift (G). Reported price: $0.00 (charitable donation, not a market sale).
• Shares transferred: 86,166 shares. No proceeds were received.
• Shares owned after transaction: Not stated in the filing.
• Footnote: F1 — the donation is to a charity, not a market transaction; the reporting person does not control or affiliate with the donee.
• Timeliness: The Form 4 was filed seven days after the transaction (appears later than the typical two-business-day reporting requirement).

Context
Gifts are transfers for tax/charitable purposes and do not necessarily reflect the insider’s view of the company’s prospects. Because no sale or purchase occurred, this transaction provides no direct information about Kidron’s personal trading sentiment or cash proceeds.